THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER
Bas W. van Rhijn, Alexandre R. Zlotta(Mount Sinai Hospital), Ellen C. Zwarthoff(Erasmus MC), Bharati Bapat(Mount Sinai Hospital), Theodorus van der Kwast(Erasmus MC), Liyang Liu(Mount Sinai Hospital), Madelon N Van der Aa, Rati Vajpeyi, Chris H. Bangma(Erasmus MC), Michael Jewett(University of Toronto), Neil Fleshner(University of Toronto)
Cited by 8
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654